Supporting our Partner Companies with Veteran Advice
At Safeguard Scientifics, we offer our partner companies quality resources to promote their growth and help them recruit strong management teams for their future. We…
Posted by
Safeguard Insights
VIDEO: Building Value and Well-timed Exits. A Look Back at Recent Successes
The past 12 months have exciting at Safeguard Scientifics. In December of 2010, partner companies Clarient and Avid Radiopharmaceuticals were both acquired by giants in…
Posted by
A Focus on Life Sciences
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…
Posted by
Safeguard Scientifics Second Quarter 2011 Financial Results Recap
This morning, we announced our second quarter 2011 financial results and reported on the exciting progress we’ve made this quarter. We deployed $45.8 million of…
Posted by
Safeguard Scientifics Leads $35 Million Financing for NovaSom
Baltimore-based company provides home sleep tests for the diagnosis of obstructive sleep apnea Wayne, PA, June 27, 2011 – Safeguard Scientifics, Inc. (NYSE: SFE), a holding…
Posted by
Safeguard Scientifics Fourth Quarter and Year-End Financial Results Recap, Highlighting Aggregate Partner Company Revenue Growth, Acquisitions and IPOs
This morning, we announced our fourth quarter and year-end 2010 financial results. In 2010, our aggregate partner company revenue was $403 million, up 54 percent…
Posted by
Life Sciences Trends for 2011: Companion Diagnostics, Reimbursement and Consumerization
Last week, Safeguard Scientifics’ Life Sciences team attended J.P. Morgan’s 29th Annual Healthcare Conference and OneMedForumSF 2011 (video) in San Francisco. Our main takeaway is that…
Posted by
Discussing Life Sciences Trends at J.P. Morgan Healthcare Conference and OneMedForum
This week, our life sciences team is heading out to San Francisco to attend J.P. Morgan’s 29th Annual Healthcare Conference, one of the life science…
Posted by
Clarient and Avid Radiopharmaceuticals Complete Acquisitions
Earlier this quarter, we announced that partner companies Clarient (Nasdaq: CLRT) and Avid Radiopharmaceuticals had signed definitive agreements to be acquired by GE Healthcare and…
Posted by
